(Q44810876)

English

Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom

scientific article published in February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

0 references

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Andrew J Palmer

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Stéphane Roze

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

William J Valentine

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Giatgen A Spinas

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jonathan E Shaw

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Paul Z Zimmet

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

304-321

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Excess costs of medical care 1 and 8 years after diagnosis of diabetes: estimates from young and middle-aged incidence cohorts in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs of type 2 diabetes in Germany. Results of the CODE-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Revealing the cost of Type II diabetes in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Diabetes Prevention Program (DPP): description of lifestyle intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Some guidelines on the use of cost effectiveness league tables

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Primer on medical decision analysis: Part 1--Getting started.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Primer on Medical Decision Analysis: Part 2—Building a Tree

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Markov models in medical decision making: a practical guide.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Primer on Medical Decision Analysis: Part 5—Working with Markov Processes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

An introduction to Markov modelling for economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Outline of a diabetes disease management model: principles and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Mt. Hood challenge: cross-testing two diabetes simulation models

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

[Increased clinical and economic advantages using PROSIT (proteinuria screening and intervention) in type 2 diabetic patients].

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Subclinical states of glucose intolerance and risk of death in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

An economic analysis of interventions for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The meaning of life expectancy: what is a clinically significant gain?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring health outcomes--putting gains into perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gains in life expectancy from medical interventions--standardizing data on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of a new dietary education program to prevent type 2 diabetes in a high-risk group of Japanese male workers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Principles for enhanced recruitment of subjects in a large clinical trial. the XENDOS (XENical in the prevention of Diabetes in Obese Subjects) study experience

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

French diabetologists' standpoint on the prevention of type 2 diabetes. A survey carried out during the ALFEDIAM Convention Bordeaux 2003

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990029-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)90029-X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44810876&oldid=2104987009"